This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings: Archive
Why IPG (IPGP) International Revenue Trends Deserve Your Attention
by Zacks Equity Research
Explore how IPG's (IPGP) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
IPGPPositive Net Change
earnings geographic-revenue
Staar Surgical (STAA) International Revenue in Focus: Trends and Expectations
by Zacks Equity Research
Examine Staar Surgical's (STAA) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
STAANegative Net Change
earnings geographic-revenue
Understanding Steris (STE) Reliance on International Revenue
by Zacks Equity Research
Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
STENegative Net Change
earnings geographic-revenue
Why Teradyne (TER) International Revenue Trends Deserve Your Attention
by Zacks Equity Research
Examine the evolution of Teradyne's (TER) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
TERNegative Net Change
earnings geographic-revenue
Why KLA (KLAC) International Revenue Trends Deserve Your Attention
by Zacks Equity Research
Review KLA's (KLAC) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
KLACNegative Net Change
earnings geographic-revenue
International Markets and Capri Holdings (CPRI): A Deep Dive for Investors
by Zacks Equity Research
Review Capri Holdings' (CPRI) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
CPRIPositive Net Change
earnings geographic-revenue
Stay Ahead of the Game With Tapestry (TPR) Q4 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Tapestry (TPR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
TPRNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unlocking Q2 Potential of Nice (NICE): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Nice (NICE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
NICENegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unveiling Amcor (AMCR) Q4 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Amcor (AMCR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
AMCRPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Insights Into Applied Materials (AMAT) Q3: Wall Street Projections for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Applied Materials (AMAT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2025.
AMATNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Curious about Deere (DE) Q3 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Deere (DE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2025.
DENegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
International Flavors (IFF) Reliance on International Sales: What Investors Need to Know
by Zacks Equity Research
Examine the evolution of International Flavors' (IFF) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
IFFPositive Net Change
earnings geographic-revenue
Don't Overlook Insmed (INSM) International Revenue Trends While Assessing the Stock
by Zacks Equity Research
Explore Insmed's (INSM) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
INSMPositive Net Change
earnings geographic-revenue
Unlocking Q2 Potential of Advance Auto Parts (AAP): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Advance Auto Parts (AAP) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
AAPNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
APA Q2 Earnings Shine With Beat on Both Top and Bottom Lines
by Zacks Equity Research
APA tops Q2 forecasts with stronger production, cost cuts. and shareholder returns despite softer oil prices.
COPNegative Net Change APAPositive Net Change EQTPositive Net Change EOGPositive Net Change
earnings energy oil-energy
3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
by Ekta Bagri
Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP scores.
GILDNegative Net Change INOPositive Net Change DERMPositive Net Change ZVRAPositive Net Change
biotechnology biotechs earnings medical pharmaceuticals
Embraer's Q2 Earnings Miss Estimates, Revenues Increase Y/Y
by Zacks Equity Research
Embraer posts wider-than-expected Q2 loss despite 21.8% revenue jump, with gains across all business segments and a record $29.7B backlog.
BANegative Net Change ERJPositive Net Change LDOSPositive Net Change RTXNegative Net Change
aerospace earnings
Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract
by Zacks Equity Research
BRKR's Q2 profit drops sharply, revenues decrease, and weak demand leads to guidance cuts despite cost-saving plans.
BSXNegative Net Change BRKRPositive Net Change MEDPNegative Net Change WGSPositive Net Change
earnings medical medical-devices
PowerFleet (AIOT) Q1 Earnings Match Estimates
by Zacks Equity Research
PowerFleet (AIOT) delivered earnings and revenue surprises of 0.00% and +0.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AIOTPositive Net Change REVGNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Perion Network (PERI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Perion Network (PERI) delivered earnings and revenue surprises of +52.94% and +1.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PERIPositive Net Change SMWBPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Permian Resources Q2 Earnings Decline Y/Y on Increased Expenses
by Zacks Equity Research
PR posts a second-quarter earnings decline on higher costs and weaker prices but raises 2025 production outlook.
IMOPositive Net Change TRPNegative Net Change CTRAPositive Net Change PRNegative Net Change
earnings energy oil-energy
International Money Express (IMXI) Tops Q2 Earnings Estimates
by Zacks Equity Research
International Money Express (IMXI) delivered earnings and revenue surprises of +4.08% and -1.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IMXINegative Net Change PAGSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of +21.74% and -71.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ROIVPositive Net Change FENCPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Aaon (AAON) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Aaon (AAON) delivered earnings and revenue surprises of -29.03% and -6.16%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AAONPositive Net Change MPTIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Humacyte, Inc. (HUMA) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Humacyte, Inc. (HUMA) delivered earnings and revenue surprises of -60.00% and -73.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HUMANegative Net Change EDITPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank